Bisphosphonate-related osteonecrosis of the jaws - characteristics, risk factors, clinical features, localization and impact on oncological treatment. [electronic resource]
- Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery Jun 2012
- 303-9 p. digital
Publication Type: Journal Article
1878-4119
10.1016/j.jcms.2011.05.003 doi
Adult Aged Aged, 80 and over Angiogenesis Inhibitors--administration & dosage Antineoplastic Combined Chemotherapy Protocols--therapeutic use Arthritis, Rheumatoid--drug therapy Bicuspid Bisphosphonate-Associated Osteonecrosis of the Jaw--diagnosis Bone Density Conservation Agents--administration & dosage Breast Neoplasms--drug therapy Dental Arch--drug effects Diphosphonates--administration & dosage Drug Administration Schedule Female Follow-Up Studies Humans Injections, Intravenous Male Mandibular Diseases--chemically induced Middle Aged Molar Multiple Myeloma--drug therapy Neoplasms--drug therapy Osteoporosis--drug therapy Prostatic Neoplasms--drug therapy Retrospective Studies Risk Factors Thalidomide--administration & dosage